BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 21123778)

  • 1. Signal/noise ratios to compare tests for measuring visual field progression.
    Ernest PJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6893; author reply 6893-4. PubMed ID: 21123778
    [No Abstract]   [Full Text] [Related]  

  • 2. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual field progression.
    Medeiros FA; Weinreb RN
    Ophthalmology; 2010 Apr; 117(4):851-2; author reply 852. PubMed ID: 20346830
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulsar perimetry in the diagnosis of early glaucoma.
    Gonzalez de la Rosa M
    Am J Ophthalmol; 2011 Sep; 152(3):500-501. PubMed ID: 21855674
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlating Structural and Functional Damage in Glaucoma.
    Torres LA; Hatanaka M
    J Glaucoma; 2019 Dec; 28(12):1079-1085. PubMed ID: 31478953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning laser polarimetry and progression of visual field defects after intraocular pressure increase.
    Lopes JF; Susanna R
    Arch Ophthalmol; 2003 Oct; 121(10):1500-1. PubMed ID: 14557197
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued visual field progression in eyes with prior visual field progression in patients with open-angle glaucoma.
    Chen PP; Cady RS; Mudumbai RC; Ngan R
    J Glaucoma; 2010 Dec; 19(9):598-603. PubMed ID: 20179616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flicker-defined form perimetry in glaucoma patients.
    Horn FK; Kremers J; Mardin CY; Jünemann AG; Adler W; Tornow RP
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):447-55. PubMed ID: 25511293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage.
    Jonas JB; Stroux A; Martus P; Budde W
    J Glaucoma; 2006 Jun; 15(3):206-12. PubMed ID: 16778642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.
    Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
    Am J Ophthalmol; 2005 Jun; 139(6):999-1009. PubMed ID: 15953429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma.
    Chauhan BC; Nicolela MT; Artes PH
    Ophthalmology; 2009 Nov; 116(11):2110-8. PubMed ID: 19500850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "Curse" of the Fellow Eye in Glaucoma.
    Varma R; Jiang X
    JAMA Ophthalmol; 2018 Oct; 136(10):1156-1157. PubMed ID: 30098139
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between visual field sensitivity and macular ganglion cell complex thickness as measured by spectral-domain optical coherence tomography.
    Cho JW; Sung KR; Lee S; Yun SC; Kang SY; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6401-7. PubMed ID: 20631238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of frequency doubling technology (FDT) in glaucoma screening.
    Quaranta GM; Vetrugno M; Trabucco T; Cantatore F; Cardia L
    Acta Ophthalmol Scand Suppl; 2000; (232):21-3. PubMed ID: 11235516
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.
    Boland MV; Zhang L; Broman AT; Jampel HD; Quigley HA
    Ophthalmology; 2008 Feb; 115(2):239-245.e2. PubMed ID: 18082888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships in normal and glaucomatous eyes determined by time- and spectral-domain optical coherence tomography.
    Lee JR; Jeoung JW; Choi J; Choi JY; Park KH; Kim YD
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6424-30. PubMed ID: 20592233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.
    Chauhan BC; Mikelberg FS; Balaszi AG; LeBlanc RP; Lesk MR; Trope GE;
    Arch Ophthalmol; 2008 Aug; 126(8):1030-6. PubMed ID: 18695095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.